Heimdall Insights

Global Obsessive-Compulsive Disorder Drugs Market

Sizing, Segmentation, & Growth Forecast (2025-2030)

Last updated: August 2026

Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.

Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).

1. Summary

The Global Obsessive-Compulsive Disorder Drugs Market was valued at $820 mn. in 2025. During the forecast period 2025-2030, it is expected to grow at 9.2% CAGR, to an estimated market size of $1.3 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The global Obsessive-Compulsive Disorder (OCD) drugs market encompasses the sale of pharmaceutical therapies specifically indicated or used off-label for the management of OCD symptoms. This includes Selective Serotonin Reuptake Inhibitors (SSRIs), Tricyclic Antidepressants (TCAs), and adjunctive treatments such as antipsychotics and emerging glutamate-modulating agents. The scope excludes standalone psychotherapy and non-pharmacological medical devices unless they are part of an integrated drug-delivery system.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Obsessive-Compulsive Disorder Drugs Market in the period 2025-30:

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:

Geographies

  • North America
  • Europe
  • Asia-Pacific
  • Rest of World

Segments

  • SSRIs
  • TCAs
  • Other Drugs (Antipsychotics, NMDA blockers, etc.)